A
valvulotomy is a surgical operation used to treat regurgitation or stenosis of
the valves using a valvulotome. The impacted valve leaflets are made to have
controlled incisions made in them. Proper blood flow within the heart can be
restored by widening and improving the performance of constricted valves
through these incisions.
The Global Cardiac Valvulotome Market is estimated to be valued at US$ 157.2 Mn in 2024 and is expected to
exhibit a CAGR of 4.5% over the
forecast period 2024 to 2031.
Market Dynamics
The market is anticipated to rise as aortic stenosis becomes more common.
Aortic stenosis is a disorder that causes the aortic valve to narrow and
obstruct the flow of blood from the heart's left ventricle to the rest of the
body. Using a cardiac valvulotome can help treat this problem. In cases of
severe aortic stenosis, a valvulotome can be used to perform a valvulotomy
operation when surgical intervention is required.
The aortic valve's bulky or fused leaflets are precisely sliced during this
surgical treatment to increase the valve's openness. Breathlessness and chest
pain are temporarily relieved as a result of the improved valve's flexibility
and decreased cardiac pressure. But it might
Key
Takeaways
Key players operating in the Cardiac
Valvulotome Market Growth are LeMaitre, INVAMED, GeoSurgical, LimFlow,
Inc., B. Braun SE, Teleflex Incorporated, StarFish Product Engineering Inc.,
Koven Technology Canada Inc., Andramed, Zgrum Medical, BD, PEAK SURGICAL, and
Symmetry Surgical Inc.
The rising geriatric population across the world coupled with the growing
burden of cardiovascular diseases has fueled the demand for cardiac
valvulotomies. As per estimates, over 16 million deaths annually can be
attributed to cardiovascular diseases globally. The number of cardiac
valvulotomies performed is expected to rise significantly in tandem.
Advances in valve scoring and cutting technologies have enabled clinicians to
perform valvulotomies using minimally invasive techniques such as transcatheter
procedures. Innovations such as steam valvulotomes and rotary cutting
valvulotomes have increased the efficacy and safety of cardiac valvulotomies.
This has boosted the cardiac valvulotome market.
Market trends
There is an increased adoption of steam valvulotomes for cardiac valvulotomies
due to their precision in cutting and minimal injury to heart tissues.
Manufacturers are also developing miniaturized valvulotomes compatible with
transcatheter procedures to expand treatment options.
Improved valve materials and sealing technologies are allowing innovations such
as bio-prosthetic valves that do not require lifelong anticoagulation. This
could affect demand for cardiac valvulotomies over the long-run.
Market Opportunities
The rising geriatric population susceptible to valvular heart diseases in Asia
Pacific and Latin America provides significant opportunities for cardiac
valvulotome manufacturers. These regions are expected to be high growth
markets.
Technological advances including robot-assisted valvuloplasty may provide newer
opportunities. Integration of steerable catheters, real-time imaging, and tactile
feedback could enhance precision of minimally invasive valvulotomies.
Impact of COVID-19 on Cardiac
Valvulotome Market Growth
The COVID-19 pandemic has greatly impacted the growth of the cardiac
valvulotome market. During the initial phases of the pandemic in 2020, almost
all elective cardiac procedures were postponed to focus on treating COVID-19
patients. This led to a major decline in demand for cardiac valvulotomes amid
lockdowns and restrictions. However, as the pandemic has progressed, the market
has started recovering. With increasing vaccination rates, hospitals have
gradually resumed elective cardiac procedures while following strict safety
protocols. This has improved the demand outlook for valvulotomes from 2022
onwards.
Despite the initial setback, the long-term demand drivers for valvulotomes
remain strong. The rising geriatric population which is more prone to cardiac
valve diseases continues to bolster market growth. Furthermore, technological
advancements introducing minimally invasive procedures are encouraging more
cardiac interventions. This is expected to further aid the market recovery in
the post-COVID period. However, supply chain disruptions caused due to the
pandemic may continue affecting market players to some extent. Overall, while
short-term growth was impacted by COVID-19, the focus on resuming cardiac
treatments indicates steady recovery of the valvulotome market over the coming
years.
Geographical Regions with Highest Valu
of Cardiac Valvulotome Market
In terms of value, North America dominated the global cardiac valvulotome
market and accounted for the largest share till the COVID-19 pandemic. This was
mainly attributed to the region's advanced healthcare infrastructure and rising
prevalence of valvular heart diseases. However, with elective surgeries being
postponed in 2020-2021, the regional market did witness a decline. Asia Pacific
is now emerging as the fastest growing market for cardiac valvulotomes.
Countries like China, India, and Japan are experiencing a rapid rise in aging
population as well as growing healthcare expenditure, propelling market growth.
Besides, increasing medical tourism in Asia Pacific for cost-effective cardiac
treatments is also boosting regional demand.
Fastest Growing Region for Cardiac
Valvulotome Market
Asia Pacific region is projected to be the fastest growing market for cardiac
valvulotomes over the forecast period from 2024 to 2031. This growth can be
attributed to various factors. Firstly, the rising geriatric demographic which
is more prone to valvular heart diseases will drive the need for cardiac
valvulotome procedures. Secondly, improving public healthcare infrastructure
and increasing healthcare spending is enhancing the diagnosis and treatment
rates. Thirdly, developing medical device manufacturing capabilities in Asia
Pacific economies is augmenting the regional supply of valvulotomes.
Furthermore, favorable government initiatives to promote affordable healthcare
accessibility will continually support market expansion in Asia Pacific. Thus,
the cardiac valvulotome market is likely to witness substantial gains across
developing Asia Pacific nations in the coming years.
Get more insights on Cardiac
Valvulotome Market
|
Comments
Post a Comment